The underdiagnosis and consequent undertreatment of sleep-disordered breathing in the CF population can compromise patients’ overall outcomes.
Modulators of the cystic fibrosis transmembrane conductance regulator protein have emerged as a promising therapeutic strategy for CF.
Our ability to tackle neutrophilic inflammation while maintaining healthy immune function may be key to tackling cystic fibrosis lung disease.
We investigate the importance of nutrition and weight management and monitoring in the care of patients with cystic fibrosis.
We discuss strategies for antibiotic therapy in the management of cystic fibrosis pulmonary exacerbations.